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In June 2013 the Japanese Ministry of Health, Labor, and Welfare (MHLW) suspended its HPV vaccination
recommendation after a series of highly publicized alleged adverse events following immunization stoked public
doubts about the vaccine’s safety. This paper examines the global spread of the news of Japan’s HPV vaccine
suspension through online media, and takes a retrospective look at non-Japanese media sources that were used to
support those claiming HPV vaccine injury in Japan. Methods: Two searches were conducted. One searched relevant
content in an archive of Google Alerts on vaccines and vaccine preventable diseases. The second search was conducted
using Google Search on January 6th 2014 and on July 18th 2014, using the keywords, “HPV vaccine Japan” and “cervical
cancer vaccine Japan.” Both searches were used as Google Searches render more (and some different) results than
Google Alerts. Results: Online media collected and analyzed totalled 57. Sixty 3 percent were published in the USA, 23%
in Japan, 5% in the UK, 2% in France, 2% in Switzerland, 2% in the Philippines, 2% in Kenya and 2% in Denmark. The
majority took a negative view of the HPV vaccine, the primary concern being vaccine safety. Discussion: The news of
Japan’s suspension of the HPV vaccine recommendation has traveled globally through online media and social media
networks, being applauded by anti-vaccination groups but not by the global scientiﬁc community. The longer the
uncertainty around the Japanese HPV vaccine recommendation persists, the further the public concerns are likely to
travel.
Introduction
According to the World Health Organization (WHO),
“cervical cancer is the second most common cancer in women
in the world and the third greatest cause of death from cancer
in women.”1 Every year, about 270,000 women die of cervical
cancer, over 85% of whom are in developing countries.2 Sev-
enty percent of cervical cancers are caused by 2 strains of human
papillomavirus: HPV 16 and 18. Currently, there are 2 vaccines
that protect against both of these strains of HPV: Cervarix
and Gardasil. HPV vaccines are currently licensed for use in
128 countries.3 Despite its proven benefits, the HPV vaccine
brings challenges. First, as it is given in adolescence, it needs
a different delivery mode than for childhood vaccines.
In addition, as the vaccine prevents a sexually transmitted infec-
tion (STI), it evokes the moral judgments and religious and cul-
tural taboos that come with discussing and addressing sexual
behavior and there have been concerns about it increasing sexual
promiscuity. Research, however, has confirmed that adolescents
who have received the HPV vaccine are not more sexually active
than their peers.4
In Japan, the HPV vaccine (Cervarix) was licensed in Octo-
ber 2009 and 4 y later, in April 2013, the HPV vaccine was
added to the government of Japan’s list of recommended vaccina-
tions. Yet, in June 2013, the Japanese Ministry of Health,
Labor and Welfare (MHLW) suspended the pro-active
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recommendation of HPV vaccination after a series of highly pub-
licised alleged adverse events following immunization (AEFI)
stoked public doubts about the vaccine’s safety. The vaccine con-
tinued to be provided for free to girls aged 12–16 y when asked
for. The MHLW has added a page on its website (last updated
on June 21, 2013) with a Q&A about the HPV vaccine, includ-
ing a section on the safety of the vaccine5 and has issued guidance
to health care professionals.6 However, despite these efforts to
create more positive awareness of the vaccine’s safety, the gov-
ernment’s decision to suspend the active recommendation while
continuing to provide the HPV vaccine on demand has led to
the spread of uncertainty and distrust.
Adverse events and media coverage
The local media reports of alleged adverse events and negative
information available internationally on the internet have con-
tributed to the Nationwide Cervical Cancer Victim Liaison
Committee’s gaining considerable strength and public attention
in Japan. The Committee is headed by a parent who tried to
claim compensation for her daughter’s suspected complex
regional pain syndrome (CRPS), claiming that her daughter lost
the ability to walk after vaccination with Cervarix and is now in
a wheelchair.7 The national government refused compensation
because the vaccination was not yet in the National Immuniza-
tion Program. The local government of Suginami, where the
girl’s family lived, also initially refused to provide compensation,
but after the case was reported at a local assembly meeting in
April 2013, where the victims’ group criticized the local govern-
ment, intense media scrutiny prompted Suginami to provide
compensation.8 (See Table 1). The public perceived this as an
admission of guilt and the issue became a tipping point for cur-
rent anti-HPV vaccine sentiment.
In suspending its recommendation, the MHLW declared that
it would investigate the reported cases of AEFI but as of July
2014, the only conclusion that has been reached is that the AEFIs
were not caused by the vaccine but were psychosomatic or psy-
chogenic. Because of the government’s continued suspension of
the HPV vaccine recommendation, despite the investigation
reporting no causal AEFI, other actors have filled the information
void.
Politician Toshie Ikeda is secretary-general of the Nationwide
Cervical Cancer Vaccine Victim Liaison Committee, which is
a victim support group. She uses her Twitter account and
Facebook page to promote the group’s concerns. The absence of
any media watchdog in Japan and relatively lax libel laws mean
that newspapers, news programs, social networks, and victim sup-
port groups are able to publish unverified stories and videos of
girls who claim to suffer from adverse events following HPV vac-
cination, as well as discredit or make slanderous comments about
health professionals and organizations promoting the HPV
vaccine.
Media coverage and public perceptions
According to Marimoto et al. the media coverage of adverse
events was most frequent around March 2013 and again after the
government’s June 2013 announcement that it would be sus-
pending its HPV vaccine recommendation while further investi-
gating the reported adverse events. In 2013, the first dose
vaccination rate of the HPV vaccine decreased by 97% compared
with the same month in the previous year.9 A study conducted
by Marimoto et al.9 found that the news of adverse events
affected the attitude toward vaccination more strongly than the
governmental announcement (91% and 68% respectively). Out
of 2,777 study registrants, 80% had heard about the HPV
vaccine’s adverse events and 68% were aware of the governmental
decision to suspend pro-active recommendation of the vaccine.
Twenty-9 percent discontinued vaccination after hearing negative
news reports.
The decision of the Japanese Ministry of Health, Labor and
Welfare to withdraw its recommendation of the HPV vaccine,
together with the Japanese media’s often negative view of the vac-
cine, are reinforcing the confusion and uncertainty surrounding
vaccination.
This paper examines the global spread of information and per-
ceptions around Japan’s suspension of its HPV vaccine recom-
mendation through an analysis of online media. It particularly
Table 1.Major events in Japan related to the HPV vaccine
October 2009 Cervarix licensed in Japan.
March 2010 After HPV vaccination, 3 girls complain of CRPS and 9 from chronic pain.
April 2010 32 of 1,747 local governments were providing funding for the HPV vaccine.
October 2010 Central and all local governments launch a temporary funding program, with central governments providing 50% for those
local governments paying 50%.
July 2011 Gardasil licensed in Japan.
08 March 2013 Asahi newspaper press report of 50 girls suffering from CRPS and 100 absent from school after receiving the HPV vaccine.
10 March 2013 Adverse events reported on TV news.
25 March 2013 Press conference by “victim” group showing videos of girls suffering from walking disturbances and seizures, which was also
posted on YouTube.
01 April 2013 HPV vaccine included in the National Immunisation Program (NIP). Optional and given for free to girls aged 12–16 y old.
13 April 2013 Suginami local government announces its budget for the next ﬁscal year. This included compensation claimed by the parents
of a girl with suspected CRPS following HPV vaccination. Case reported at local assembly meeting.
19 May 2013 Another press conference by victim group.
13 June 2013 WHO Global Advisory Committee on Vaccine Safety report released stating HPV vaccine is safe. Not reported in Japanese
media.
14 June 2014 Joint meeting of the Vaccine Adverse Reactions Review Committee (VARRC). MHLW decided to temporarily suspend
recommendation of HPV vaccine.
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examines how Japanese
online media refer to online
reports in other countries
which are critical of the HPV
vaccine to substantiate their
own concerns in Japan.
Additionally, it examines
how anti-HPV vaccine web-
sites and online discussions
outside of Japan use—and
applaud—the Japanese gov-
ernment’s decision to sus-
pend active recommendation
of the HPV vaccine as sup-
port for their own concerns,
contributing to the building
of global networks of like-
minded beliefs toward the
HPV vaccine.
Results
Total online media col-
lected through the combined
Google Alerts and Google
Searches totalled 57 and included 40 (70%) website pages, 8
(14%) online newspaper articles, 3 (5%) social media pages, 2
(4%) technical reports, one (2%) government announcement, 2
(4%) online blog, and one (2%) YouTube video. There were 36
(63%) from the USA, 13 (23%) from Japan, 2 (4%) from the
UK, one (2%) from France, one (2%) from Switzerland, one
(2%) from the Philippines, one (2%) from Kenya, and one (2%)
from Denmark.
Fifty-two (91%) articles were published in English, 4 (7%) in
Japanese, and one (2%) in French. Some articles (e.g. on a US
website) included comments from various other countries (Can-
ada, Norway and the UK). Japan media reported on the HPV
vaccine situations in the USA and France (Fig. 1). The major-
ity—46 (81%) took a negative view of the HPV vaccine. Only 7
(12%) portrayed positive sentiment and 4 (7%), neutral senti-
ment. The concern of all the negative articles were the safety of
the HPV vaccine. Most of the articles concerned HPV and
females—52 (91%). Four concerned both males and females
(7%) and one (2%) did not mention a gender. Forty-three
articles (75%) were published in 2013, 12 (21%) in 2014. (Two
articles—4% had no date).
Six of the articles were identified through Google Alerts using
the search term “HPV Japan” and all 6 were website pages. There
were 5 from the USA and one from the UK. All articles were
published in English. Five (83%) took a negative view of the vac-
cine against HPV. Only one (17%) portrayed positive sentiment.
All 6 of the negative articles expressed concerns about the safety
of the HPV vaccine. All of the articles focused on HPV and
females.
Through the Google Search, using the terms “HPV Japan”
and “cancer vaccine Japan,” 51 reports were collected and ana-
lyzed and included 35 (69%) website pages, 8 (16%) online
newspaper articles, 3 (6%) social media pages, 2 (4%) technical
reports, one (2%) government announcement, one (2%) online
blog and one (2%) YouTube video. There were 31 (61%) from
the USA, 13 (25%) from Japan, 2 (4%) from the UK, one (2%)
from France, one (2%) from Switzerland, one (2%) from the
Philippines, one (2%) from Kenya and one (2%) from Denmark.
Forty-6 (90%) articles were published in English, 4 (8%) in
Japanese and one (2%) in French. The majority—41 (80%) took
a negative view of the vaccine against HPV. Only 6 (12%) por-
trayed positive sentiment and 4 (2%) neutral sentiment. The con-
cern of all the negative articles was the safety of the HPV vaccine.
Ninety percent of the articles (46) concerned HPV and females.
Four concerned both males and females (8%) and one (2%) did
not mention a gender. Forty-three articles (84%) were published
in 2013, 6 (12%) in 2014. (Two articles—4% had no date).
Tag cloud
A word frequency tag cloud was created for all online media
articles collected (see Fig. 2). As illustrated, given that the key
search terms for the articles featured “HPV,” “vaccine,” and
“Japan,” it is not surprising that the highest frequency words are
HPV (which appeared 1605 times within the articles), vaccine
(1531 times) and Japan (780), Additional words frequently
occurring are Gardasil (634), health (572), cancer (541), 2013
Figure 1. Map showing global transmission of: 1) Information about other countries’ HPV situation reported in the
Japanese media; and 2) reporting and discussion on the Japanese suspension of the HPV vaccine recommendation
outside of Japan. (January 2014-July 2014).
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(522), cervical (428), adverse (314), government (293), effects
(255), safety (255), and withdraws (186).
Discussion
Inside Japan
The majority of online media articles from Japan reporting on
the HPV situation do not mention HPV vaccination in other
countries around the world, apart from one article in the Asahi
Shimbun,10 which quotes Ryo Konno, of the Jichi Medical Uni-
versity’s Saitama Medical Center, who heads a group promoting
the vaccination and stated that no other country has suspended
recommending the vaccination, and one in the Tokyo Times,
which compares the decision of the Japanese government with
the United States Health Official’s recommendation that teen-
agers should be vaccinated more after a study showed that the
vaccine is highly effective. Where the particularly conflictual dis-
cussions and references to other countries appear are in the
“comments” section following the articles, where one comment,
for instance, states, “At least Japan’s health ministry is interested
in protecting their young women’s health versus the USA who
only cares to protect their corpo-
rate profit.” Other comments
include links to a number of anti-
HPV websites or online articles
from the USA. The Asahi Shimbun
reported that many parents and
municipal government officials
said they are confused by the min-
istry’s decision to withhold its rec-
ommendation and that the
government and experts are evad-
ing their responsibility.11
The Cervical Cancer Vaccine Q
& A page on the MHLW website11
states that it is up to the public
(individual or parent) to judge
whether or not to receive the HPV
vaccine. At the end of the page
there is also a paragraph on com-
pensation available due to side
effects. The vice president of the
International University of Health
and Welfare, Mariko Momoi, who
heads a ministry task force looking
into the alleged AEFI, stated in the
Asahi Shimbun that the decision
does not mean that the vaccine
itself is problematic from the view-
point of safety and that by imple-
menting investigations, they can
offer more information to make
the people feel more at ease.11
However, in the Japan Times,
Momoi states that there was a
strong possibility that severe prolonged pain was caused by some
of the vaccinations.12 The Japan Times also reported on the ado-
lescents allegedly injured or disabled by the HPV vaccine, making
the point that Cervarix and Gardasil are not domestic vaccines,
but manufactured by UK and US pharmaceutical companies.13
Another example of this confusing rhetoric in the online
media is the Japanese website, Gekkan Nippon.14 A reporter inter-
viewed Masayuki Sasaki, Director of the Pediatric Neurology
Department at NCNP Hospital who, after seeing “victims” of
the HPV vaccine, concluded there is a high possibility that the
symptoms supposedly suffered, were adverse reactions to the vac-
cine. He also reported that similar symptoms to those reported
had been seen in France after Hepatitis A or B vaccination, and
makes reference to French articles that point to adjuvants as the
problem. The reporter criticizes WHO, as well as the Japanese
government. In addition to safety concerns, negative sentiment
linked to dissatisfaction and distrust of government was a recur-
ring theme within anti-vaccine articles.
USA media
Thirty-six relevant articles were collected from the USA. Out
of these articles, 27 were published in 2013, 8 in 2014 and one
Figure 2. Word frequency tag cloud analysis of online media identiﬁed through both the Google Alert and
Google Searches (all articles were published between April 9th 2013–June 25th 2014).
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article did not mention a date. Several anti-vaccine websites, such
as Age of Autism, quote a report written by Dr. Sataro Sato, a Jap-
anese internist and cardiologist, which details numbers and types
of adverse events following vaccination (AEFI), including brain
damage.15 Many websites refer to the number of adverse events
reported in Japan, citing that nearly 2,000 adverse events were
reported, of which 385 were evaluated as serious. Some claim
that the vaccine has caused numerous deaths.16 Articles also pro-
vide petitions urging the abolition of the vaccine for readers to
sign, to be handed to the Japanese Minister of Health, Norisha
Tamura. Authors inaccurately describe “the virtually non-existent
risk posed by being infected with ‘so-called’ carcinogenic HPV”17
and provide links to the 2013 Japanese press conference that
shows videos of girls suffering from walking disturbances and
seizures.18 An article in ChildHealthSafety19 which reported on
the suspension of the vaccine recommendation also suggested
gender inequality as a reason that some health professionals are
not listening to women who claim to suffer AEFIs.
One US article surmised that because Japan suffers from “the
lowest fertility rates in the world,” officials are “being extremely
cautious in implementing any long term health initiatives which
affect women’s reproductive organs.”20
Of the US articles, 14 specifically contrasted Japan’s decision
to withdraw the recommendation of the HPV vaccine to the situ-
ation in the USA. Thirteen articles applaud Japan for setting a
good example: “finally the truth arrives from Japan”21 “health
authorities around the globe could learn from Japan’s demonstra-
tion of genuine concern for the health and well-being of their cit-
izens,”22 “the Japanese government would make common sense
decisions based on evidence and stop allowing administration of
an obviously dangerous vaccine without warning, while stateside
our FDA is still dutifully telling Americans not to worry, go
ahead and take the shot- it is ’safe and effective”23 and “Why are
our government officials not doing the same thing?”24 The
articles express suspicion and question why the USA is pushing a
vaccine which allegedly causes severe adverse effects. Some
articles state that the “US government has taken the opposite
approach amid equally alarming cases of serious side effects.”25,26
Erickson27 also questions how the US health and government
officials are dealing with the situation of severe adverse events
due to HPV vaccination. In the comments section to this article
there are people from Norway, Canada, the USA and the UK
applauding the Japanese government’s decision and questioning
or critiquing their own countries’ policy. One person notes “This
(Japanese) press release . . . should certainly be widely spread. . . it
is also extremely important because it will surely be an inspiration
and encouragement for anti-vaccine advocates in other
countries.” A few articles are neutral and merely report the
MHLW’s decision to halt recommendation of HPV vaccination.
Only one of the US articles comparing the Japan situation with
the situation in the US focused on the positive sentiment of the
HPV vaccine within the US medical community. The article
compared the MHLW’s decision to halt recommendation of
HPV vaccination with the positive results from a study con-
ducted in the US showing that HPV types that commonly
cause cervical cancer has dropped by 56 percent in teenage
girls since Gardasil was introduced in 2006.28 Some American
websites also compare other countries’ decisions regarding the
HPV vaccine, with that of Japan. PRweb.com compares Japan,
Israel, and Italy, (where health officials are re-evaluating the
safety of the HPV vaccine), to the USA, which is still promot-
ing the vaccine. The article quotes Greg Bennet, Center for
the Biology of Chronic Disease (CBCD), as saying “We won-
der why the CDC and FDA are pushing Gardasil so strongly
when health ministries in other countries are expressing
concern.”29
Other international media
We collected 7 relevant online media articles from outside of
Japan and the USA, referring to events concerning the govern-
ment decision on HPV vaccination in Japan. There were 2
articles from the UK, one in June 201330 and one in May
2014.31 In July 2013 there was one article from Denmark,32 one
from Kenya,33 one from the Philippines,34 and one from Switzer-
land.35 In November 2013 there was one additional article col-
lected from France.36
Of these 7 articles, 4 articles correctly state that the Japanese
Ministry of Health suspended proactive recommendation of the
HPV vaccine,31-33,36 2 misstated that it withdrew administration
of HPV vaccines.34,35
The WHO Weekly Epidemiological Record reported on the rec-
ommendations of the Global Advisory Committee on Vaccine
Safety (GACVS) with regard to the Japanese situation. Although
the Committee met before the Japanese government decision
and stated no reason to suspend the vaccine nor vaccination rec-
ommendation, their advice did not deter the Japan decision to
temporarily suspend the HPV vaccination recommendation. The
Global Vaccine Safety Committee reviewed updated information
about the safety of HPV vaccines since their last review in June
2009. The article states that “data from all sources continue to be
reassuring about the safety of both vaccines” however it also states
that “risk of syncope and anaphylaxis have been added to the
label to warn of these potential events, the former being also pos-
sibly related to conditions around the vaccination experience
itself.36 The committee discussed the cases from Japan initially
resembling complex regional pain syndrome and that these have
received media attention. It notes that while these cases are under
investigation, “Japan has continued to provide HPV vaccine in
their national program.” Recognizing the public concerns voiced,
the Committee urges careful documentation of each case and a
thorough search for a definitive diagnosis by medical specialists
in order to best guide treatment. A timely clinical assessment and
diagnosis of each case followed by appropriate treatment is there-
fore essential.”36
Of the international articles collected that correctly state that
the recommendation was withdrawn, reasons for doing so over-
state “hundreds of complaints from Japanese citizens about possi-
ble side effects such as long-term pain, numbness and even
paralysis,”31 in combination with “in an attempt to avoid
completely alienating the World Health Organization, which rec-
ommends the HPV vaccine used by many developed nations, the
Ministry of Health, Labor and Welfare insisted that it is not
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suspending the use of the vaccine, but simply instructed local
Japanese governments not to promote it until more study is con-
ducted on its safety.31
Nsnbc international, an alternative news site, reported on
the Japanese health authorities’ decision to withdraw their
recommendation for HPV vaccine due to high levels of seri-
ous adverse reactions. It refers to an article from the USA
by Sanevax Inc. claiming the rate of serious adverse reactions
which Japanese women experienced after Cervarix as
52 times the rate of those reported after annual influenza
vaccines.33
Concerns in all 7 articles ranged from a perceived lack of need
for an HPV vaccine,31,33 a lack of effectiveness34 and concerns
about potential adverse events following immunization.31–36
Cervical cancer is an “extremely rare disease . . .the risk is nor-
mally zero up to age 20 . . .by the time there is any risk. . .any
effect from the vaccine [if there ever was one] would have worn
off.”33 “Critics argue the vaccines have not been in the market
long enough to provide conclusive proof they can prevent cervical
cancer.”34 Comments posted below theukcolumn.com article
question the importance of the HPV vaccine due to a belief that
HPV does not cause cancer, and that HPV “goes away by
itself.”31 Reported concerns of adverse events following immuni-
zation include syncope, anaphylaxis, sterilization, death, precan-
cerous lesions, convulsions, seizures, severe headaches, partial
paralysis deafness, blindness, head banging, and foaming at
mouth.31-36
The Catholic Philippines article states that the Japanese gov-
ernment withdrew administration of HPV vaccines, “citing
adverse effects including infertility, long-term pain, numbness
and paralysis.35 The Kenyan article also refers to concerns over
fertility suggesting that since the Japanese have a low fertility
rate, “anything that poses any threat to their fertility is likely to
cause alarm bells to ring.”34 “While Kenya’s fertility rate is one
of the highest in the world, such potential threats to fertility
should not be overlooked."34 The theukcolumn.com article re-
iterates that Japan is suffering from one of the lowest fertility
rates in the world and notes that Japan is “being extremely cau-
tious in implementing any long-term health initiatives which
affect women’s reproductive organs.”31 It also cites a US article
in The Wall Street Journal about “a Japanese program that pays
new parents $3,300 per year for every new child until age 15,”
among other less direct incentives to increase birth rate. The
ukcolumn article also suggests that vaccinations may be deadly,
stating “in 1975, Japan eliminated all vaccines for children under
the age of 2. The country’s infant mortality rate subsequently
plummeted to the lowest level in the world.”31 Comments posted
below the UK June article refer to concerns about side effects,
including HPV vaccination causing an increase in the risk of pre-
cancerous lesions.
The nsnbc international site states “it is obvious that anyone
proposing to have this vaccine needs to be screened for (1) pre-
existing medical conditions putting them at risk and (2) risk of
adverse reactions based on prior clinical history. That is not being
done.”33 One comment agrees with the report and states “the
entire vaccination racket is run by a bunch of psychopathic
maniacs who will do everything they can to disguise the system-
atic poisoning of babies and children for profit as
immunization.”33
Other topics discussed in the articles were distrust of HPV
vaccines by the Japanese government,31,34 questions of motives
of WHO and FDA,34,35 motives of UK’s BBC,33 distrust of
MHRA,33 business motives,31,35 and political motives.31 Some
applauded Japan, while criticizing their own government’s deci-
sions, such as an online article in the French newspaper, Le
Monde, which questioned why the French government is not
being as sensibly cautious as the Japanese government.37
The Kenyan article states “in effect, the Japanese Ministry of
Health is saying quite categorically that it has no faith in Gardasil
and Cervarix”34 and the UK June article states that “the Japanese
health ministry doesn’t trust the HPV vaccines Gardasil or
Cervarix.”31 The Kenyan article questions motives of the WHO
and the FDA, stating that “the World Health Organization faces
stinging criticism” and that “critics have accused the WHO of
promoting the vaccines to benefit the manufacturers. The same
criticism has been levelled against the United States Food and
Drug Administration.”34 The Catholic Philippines article, citing
an article from the US and one article from Kenya, ‘Catholic
Philippines’, a community with over 1,000 likes on social media
site Facebook, re-posted and provided a link to an article in the
US-based Examiner.com stating that “World Health Organiza-
tion accused of promoting vaccines to benefit manufacturers,”
and citing an article in Standard Digital from Kenya, “critics
have accused the WHO of promoting the vaccines to benefit the
manufacturers and that the same criticism has been levelled
against the United States Food and Drug Administration.”35
Comments posted below the UK June article refer to concerns
business motives, political motives of Texas governor Rick Perry
making Gardasil vaccinations mandatory while having “heavy
connections with the pharmaceutical industry.”31
Nsnbc international wrote about the UK drug safety agency
falsifying vaccine safety data and claiming that the MHRA
encouraged health professionals not to report adverse reactions.
“Chief Executive Professor Sir Kent Woods telling health profes-
sionals that reactions can be “psychogenic”—or in simpler terms
a figment of 12 y old schoolgirls’ imaginations” and states
“Professor Woods then advised medical professionals not to
report an adverse reaction if it ‘may’ be psychogenic.”33 The arti-
cle accuses the MHRA of systematically altering data from the
suspected adverse reactions, by separating out the symptoms, and
declaring the vaccine safe when it was not, and fixing the figures
“to make the rate of adverse reactions appear lower by substitut-
ing the number of doses given for the number of children receiv-
ing the vaccine, . . . if all children received all 3 doses then the
crucial figure was not the number of doses but the number of
children who suffered reactions compared to the total number of
children.”33 The UK July article also stated that “the UK’s BBC
has become the British Government’s press office” illustrating a
distrust in the BBC.33
In analyzing the issue of vaccine hesitancy perpetuated or
caused by postings on online media, it is important to acknowl-
edge the potentially corrosive effects of rumors and their impact
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on public trust. According to experts in rumor psychology, the
content of rumor can be innocent but often deals with a set of
social concerns or public dissension. Rosnow asserts that rumor
generation is mediated by personal anxiety and general uncer-
tainty. This can refer to tangibly dangerous situations like health-
endangering contexts. This is certainly evident regarding public
confusion around the Japanese government’s decision to suspend
proactive recommendation of the HPV vaccine recommendation.
Drawing on rumor theory we can conclude that the ambiguous
and potentially threatening context generated by adverse events
following HPV vaccination, whether deemed causal or not, accel-
erate an information-seeking process, often seeking to reinforce
pre-existing beliefs and concerns.
As with other vaccines, anxieties surrounding the HPV vac-
cine must be addressed promptly, including a system that allows
the public to express concerns and receive swift, evidence-based
answers.
Like all vaccines and medicines, the HPV vaccine carries some
risks of adverse events, but they are generally minor and rare; and
most reported AEFIs are ultimately found to lack a causal con-
nection. Nonetheless, whether the reported AEFIs are minor or
serious, real or perceived, they can prompt public anxieties, as
well as affect political confidence, and appropriate responses are
critical to sustaining and rebuilding the public’s trust in the
vaccine.
Conclusion
Japan’s suspension of the HPV vaccine recommendation has
been largely applauded by the anti-vaccination groups but not by
the global scientific community. Although anti-HPV vaccine sen-
timent is not widely spread on global mainstream media, it has
spread and been reinforced through social networks in Japan and
globally, especially as other countries have faced similar chal-
lenges with HPV vaccine uptake. This has been additionally
fueled by rapid changes in communication technologies allowing
for fast, multi-user and non-hierarchical diffusion of
information.37
News of the Japanese government’s withdrawal of its active
recommendation for the HPV vaccine has reached a global
audience—often with the facts misrepresented yet replicated
word-for-word across multiple media in multiple countries. The
ambiguity in the decision to suspend “active recommendation"
of the vaccine—but not the “administration” of the vaccine—has
further allowed for multiple interpretations and misinterpreta-
tions. To give just one example, a story posted on the US-based
Examiner.com reporting that the Japanese government has
“withdrawn administration” of vaccines against HPV was
reposted on a Kenyan news site, Lifestyle, the Catholic Philippines
Facebook page, and the New Illuminati Facebook page. Many
websites reporting on the issue are copied from one source (often
Sanevax), amplifying and re-affirming perceptions of risk in what
Salathe and Khandelwal38 refer to as the “echo chamber” effect.
News reports with social media “share” functions also enable
propagation of misinformation and quick formation of affinity
groups around opinions and the limited length of tweets (the
name of messages posted on Twitter) requires people to express
opinions very concisely. This is evident when, considering that
the media coverage of the HPV vaccine issue in Japan is largely
in Japanese, the debates have still traveled quickly and influenced
discussions on HPV vaccine globally.
Limitations
As our search terms were in English, the results may be
biased toward English websites. The amount of articles found
was also limited in the Google Alerts search as we only
searched emails from 1st January 2014. As the search was con-
ducted manually, articles were deemed relevant by authors,
thus potentially leading to subjectivity. This was also true for
the sentiment analysis.
Methods
Data collection
The Vaccine Confidence Project has been archiving and mon-
itoring Google Alerts with search terms on all vaccines and vac-
cine preventable diseases since March 2010. For this paper, we
searched for all alerts on “HPV Japan” for relevant content
between January 1st 2014 and July 25th 2014. Articles were con-
sidered relevant if they discussed the Japanese government deci-
sion regarding the HPV vaccine recommendation.
An additional search was conducted using the Google Search
engine to identify relevant articles missed by the Google Alert.
The search was first run on January 6th 2014 using the keywords,
“HPV vaccine Japan” and “cervical cancer vaccine Japan.” There
were no date, language, or country limits to the data we were
searching for. A snowballing technique was used and relevant
links to the Japanese suspension of the recommendation of the
HPV vaccine or the misinterpreted suspension of the vaccine
were followed. Additional relevant links in Japanese were also
identified. An extra Google Search was conducted on July 18th
2014 using the same keywords.
Data analysis
The online media data was imported into Microsoft Excel and
NVivo 10. In Microsoft Excel, the online reports were coded by
country of origin, country referred to, language of original report,
report tone (either positive/negative/neutral), and at which gen-
der the vaccine was aimed. The coding was conducted by RW,
PP, and AP and discrepancies were discussed, additional infor-
mation collected for clarification as needed, and all discrepancies
were resolved.
The report content was coded negative if it contained any
indication of concerns about the vaccine or vaccination pro-
gram, positive if it supported vaccination and neutral if it
just stated facts regarding the suspension of proactive recom-
mendation of HPV vaccine. In NVivo 10, text frequency was
analyzed for words greater and equal to 3 letters and a word
cloud created.
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